Rystiggo savings card: as little as $0 a dose with commercial insurance

How to pay the least

Ask for the cash price

Rystiggo

Rystiggo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

Ask your pharmacy for Rystiggo’s cash price, and one or two other pharmacies too.
Rystiggo’s savings card works only with insurance from a job or one you bought.

Compare every option

Brand nameRystiggo

Authorized genericrozanolixizumab

Regular genericrozanolixizumab

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Rystiggo?

The original

–

Brand nameThe maker’s card

ONWARD Copay Assistance Program

Savings card from UCB

No insuranceNeeds insuranceNo cash price listed.

Insurance · as little as $0 a dose

In the maker’s words

“Eligible, commercially insured patients may get help with out-of-pocket costs and pay as little as $0 per dose for RYSTIGGO.”

From the maker’s offer on rystiggo.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Rystiggo itself, from the same company, sold without the brand name, and usually for less. For now Rystiggo is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Rystiggo is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

Generalized myasthenia gravis (AChR or MuSK antibody-positive)

What the FDA label says

RYSTIGGO (rozanolixizumab-noli) is a neonatal Fc receptor blocker indicated for the treatment of generalized myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) or anti-muscle-specific tyrosine kinase (MuSK) antibody positive.

Source: the FDA label for Rystiggo (UCB, Inc.), January 20, 2026. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to your pharmacy.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/rystiggo/